Maria-Luisa Maccecchini - Nov 17, 2023 Form 4 Insider Report for Annovis Bio, Inc. (ANVS)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Maria Maccecchini
Stock symbol
ANVS
Transactions as of
Nov 17, 2023
Transactions value $
$0
Form type
4
Date filed
7/3/2024, 05:16 PM
Previous filing
Apr 26, 2023
Next filing
Nov 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANVS Common Stock Gift $0 -10K -0.91% $0.00 1.09M Mar 28, 2024 Direct F1
transaction ANVS Common Stock Gift $0 -10K -0.92% $0.00 1.08M Mar 31, 2024 Direct F1
transaction ANVS Common Stock Gift $0 -10K -0.93% $0.00 1.07M Mar 31, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANVS Stock Option (right to buy) Award $0 +252K $0.00 252K Nov 17, 2023 Common Stock 252K $6.07 Direct F2, F3
transaction ANVS Stock Option (right to buy) Award $0 +109K $0.00 109K Nov 17, 2023 Common Stock 109K $6.07 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents charitable gifts donated by the reporting person. No proceeds were received by the reporting person.
F2 On June 12, 2024, stockholders of Annovis Bio, Inc. approved an amendment to the 2019 Equity Incentive Plan to increase the number of shares issuable thereunder from 2,000,000 to 3,000,000. 50% of the stock option grant listed was contingent upon the approval of such amendment and would have been forfeited if the amendment had not been approved.
F3 Stock option will vest in eight consecutive quarterly installments of 31,500 shares each on the 17th day of February, May, August and November of each year, continuing through November 17, 2025.
F4 The stock option was granted in lieu of cash payment for 2023 fiscal year bonus. 100% of the stock option grant listed was also contingent upon the aforementioned amendment to the 2019 Equity Incentive Plan to increase the number of issuable shares from 2,000,000 to 3,000,000. It would have been forfeited if the amendment had not been approved.
F5 The stock option shall vest immediately.